| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abnormal hematopoietic phenotypes in Pim kinase triple knockout mice
|
An, Ningfei
|
|
2013
|
6 |
1 |
|
artikel
|
| 2 |
A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer
|
Mellor, James D
|
|
2013
|
6 |
1 |
|
artikel
|
| 3 |
Activated N-Ras signaling regulates arterial-venous specification in zebrafish
|
Ren, Chun-Guang
|
|
2013
|
6 |
1 |
|
artikel
|
| 4 |
Adjuvant zoledronic acid therapy for patients with early stage breast cancer: an updated systematic review and meta-analysis
|
He, Mingfeng
|
|
2013
|
6 |
1 |
|
artikel
|
| 5 |
A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease
|
Wun, Ted
|
|
2013
|
6 |
1 |
|
artikel
|
| 6 |
A multicenter, open-label, phase 2 study of lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma: the MM-021 trial
|
Hou, Jian
|
|
2013
|
6 |
1 |
|
artikel
|
| 7 |
An evolving new paradigm: endothelial cells – conditional innate immune cells
|
Mai, Jietang
|
|
2013
|
6 |
1 |
|
artikel
|
| 8 |
Anti-CCR7 therapy exerts a potent anti-tumor activity in a xenograft model of human mantle cell lymphoma
|
Somovilla-Crespo, Beatriz
|
|
2013
|
6 |
1 |
|
artikel
|
| 9 |
A phase II study of sorafenib (BAY 43–9006) in recurrent diffuse large B cell lymphoma: an eastern cooperative oncology group study (E1404)
|
Greenwald, Daniel R
|
|
2013
|
6 |
1 |
|
artikel
|
| 10 |
A phase I study of ridaforolimus in adult Chinese patients with advanced solid tumors
|
Liu, Lian
|
|
2013
|
6 |
1 |
|
artikel
|
| 11 |
A prospective phase II study of L-asparaginase- CHOP plus radiation in newly diagnosed extranodal NK/T-cell lymphoma, nasal type
|
Lin, Ningjing
|
|
2013
|
6 |
1 |
|
artikel
|
| 12 |
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models
|
Capello, Michela
|
|
2013
|
6 |
1 |
|
artikel
|
| 13 |
Azacitidine in patients with WHO-defined AML – Results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group
|
Pleyer, Lisa
|
|
2013
|
6 |
1 |
|
artikel
|
| 14 |
Azacitidine might be beneficial in a subgroup of older AML patients compared to intensive chemotherapy: a single centre retrospective study of 227 consecutive patients
|
van der Helm, Lieke H
|
|
2013
|
6 |
1 |
|
artikel
|
| 15 |
Bioluminescence imaging of leukemia cell lines in vitro and in mouse xenografts: effects of monoclonal and polyclonal cell populations on intensity and kinetics of photon emission
|
Christoph, Sandra
|
|
2013
|
6 |
1 |
|
artikel
|
| 16 |
Biomarkers for determining the prognosis in chronic myelogenous leukemia
|
Sweet, Kendra
|
|
2013
|
6 |
1 |
|
artikel
|
| 17 |
B-Raf and the inhibitors: from bench to bedside
|
Huang, Tiangui
|
|
2013
|
6 |
1 |
|
artikel
|
| 18 |
Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study
|
Liu, Hui
|
|
2013
|
6 |
1 |
|
artikel
|
| 19 |
Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing glioma
|
Shen, Chan-Juan
|
|
2013
|
6 |
1 |
|
artikel
|
| 20 |
Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges
|
Han, Ethan Q
|
|
2013
|
6 |
1 |
|
artikel
|
| 21 |
Clinical significance of cytogenetic aberrations in bone marrow of patients with diffuse large B-cell lymphoma: prognostic significance and relevance to histologic involvement
|
Kim, Seon Young
|
|
2013
|
6 |
1 |
|
artikel
|
| 22 |
Comparative efficacy of tandem autologous versus autologous followed by allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
|
Kharfan-Dabaja, Mohamed A
|
|
2013
|
6 |
1 |
|
artikel
|
| 23 |
Detection of TP53 dysfunction in chronic lymphocytic leukemia by an in vitro functional assay based on TP53 activation by the non-genotoxic drug Nutlin-3: a proposal for clinical application
|
Pozzo, Federico
|
|
2013
|
6 |
1 |
|
artikel
|
| 24 |
Development and characterization of a high-throughput in vitro cord formation model insensitive to VEGF inhibition
|
Falcon, Beverly L
|
|
2013
|
6 |
1 |
|
artikel
|
| 25 |
Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation
|
Lin, Ren
|
|
2013
|
6 |
1 |
|
artikel
|
| 26 |
Differential responses to genotoxic agents between induced pluripotent stem cells and tumor cell lines
|
Lu, Yinghua
|
|
2013
|
6 |
1 |
|
artikel
|
| 27 |
Different mutations of the human c-mpl gene indicate distinct haematopoietic diseases
|
He, Xin
|
|
2013
|
6 |
1 |
|
artikel
|
| 28 |
Diverse functions of miR-125 family in different cell contexts
|
Sun, Yu-Meng
|
|
2013
|
6 |
1 |
|
artikel
|
| 29 |
DNA repair gene variants are associated with an increased risk of myelodysplastic syndromes in a Czech population
|
Belickova, Monika
|
|
2013
|
6 |
1 |
|
artikel
|
| 30 |
Early stage follicular lymphoma: what is the clinical impact of the first-line treatment strategy?
|
Michallet, Anne-Sophie AS
|
|
2013
|
6 |
1 |
|
artikel
|
| 31 |
Enhanced levels of asymmetric dimethylarginine in a serum of middle age patients with myelodysplastic syndrome
|
Štikarová, Jana
|
|
2013
|
6 |
1 |
|
artikel
|
| 32 |
Enhancing bone marrow regeneration by SALL4 protein
|
Liao, Wenbin
|
|
2013
|
6 |
1 |
|
artikel
|
| 33 |
Epigenetic changes: a common theme in acute myelogenous leukemogenesis
|
Gutierrez, Soraya E
|
|
2013
|
6 |
1 |
|
artikel
|
| 34 |
Epigenetic inactivation of the MIR129-2 in hematological malignancies
|
Wong, Kwan-Yeung
|
|
2013
|
6 |
1 |
|
artikel
|
| 35 |
Erythropoietin is a JAK2 and ERK1/2 effector that can promote renal tumor cell proliferation under hypoxic conditions
|
Miyake, Makito
|
|
2013
|
6 |
1 |
|
artikel
|
| 36 |
Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma study group
|
Kim, Seok Jin
|
|
2013
|
6 |
1 |
|
artikel
|
| 37 |
Fact or fiction - identifying the elusive multiple myeloma stem cell
|
Kellner, Joshua
|
|
2013
|
6 |
1 |
|
artikel
|
| 38 |
Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients
|
Gharbaran, Rajendra
|
|
2013
|
6 |
1 |
|
artikel
|
| 39 |
FISH+CD34+CD38- cells detected in newly diagnosed acute myeloid leukemia patients can predict the clinical outcome
|
Wang, Libing
|
|
2013
|
6 |
1 |
|
artikel
|
| 40 |
G-CSF/anti-G-CSF antibody complexes drive the potent recovery and expansion of CD11b+Gr-1+ myeloid cells without compromising CD8+ T cell immune responses
|
Rubinstein, Mark P
|
|
2013
|
6 |
1 |
|
artikel
|
| 41 |
Genomic amplification and high expression of EGFR are key targetable oncogenic events in malignant peripheral nerve sheath tumor
|
Du, Xiaoling
|
|
2013
|
6 |
1 |
|
artikel
|
| 42 |
High rate of spontaneous inhibitor clearance during the long term observation study of a single cohort of 524 haemophilia A patients not undergoing immunotolerance
|
Tagariello, Giuseppe
|
|
2013
|
6 |
1 |
|
artikel
|
| 43 |
Histone deacetylase inhibitor potentiated the ability of MTOR inhibitor to induce autophagic cell death in Burkitt leukemia/lymphoma
|
Dong, Li Hua
|
|
2013
|
6 |
1 |
|
artikel
|
| 44 |
Ibrutinib and novel BTK inhibitors in clinical development
|
Akinleye, Akintunde
|
|
2013
|
6 |
1 |
|
artikel
|
| 45 |
IGF binding protein 2 is a cell-autonomous factor supporting survival and migration of acute leukemia cells
|
Chen, Xiaoli
|
|
2013
|
6 |
1 |
|
artikel
|
| 46 |
Immunoglobulin E induces VEGF production in mast cells and potentiates their pro-tumorigenic actions through a Fyn kinase-dependent mechanism
|
Jiménez-Andrade, Guillermina Yanek
|
|
2013
|
6 |
1 |
|
artikel
|
| 47 |
Immunomodulation therapy with lenalidomide in follicular, transformed and diffuse large B cell lymphoma: current data on safety and efficacy
|
Desai, Madhav
|
|
2013
|
6 |
1 |
|
artikel
|
| 48 |
Induction of acquired drug resistance in endothelial cells and its involvement in anticancer therapy
|
Huang, Limin
|
|
2013
|
6 |
1 |
|
artikel
|
| 49 |
Induction of long intergenic non-coding RNA HOTAIR in lung cancer cells by type I collagen
|
Zhuang, Yan
|
|
2013
|
6 |
1 |
|
artikel
|
| 50 |
Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs
|
Ahmad, Aamir
|
|
2013
|
6 |
1 |
|
artikel
|
| 51 |
Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity
|
Quotti Tubi, Laura
|
|
2013
|
6 |
1 |
|
artikel
|
| 52 |
Inosine Triphosphate Pyrophosphohydrolase (ITPA) polymorphic sequence variants in adult hematological malignancy patients and possible association with mitochondrial DNA defects
|
Zamzami, Mazin A
|
|
2013
|
6 |
1 |
|
artikel
|
| 53 |
Intensity modulated radiotherapy for sinonasal malignancies with a focus on optic pathway preservation
|
Chi, Alexander
|
|
2013
|
6 |
1 |
|
artikel
|
| 54 |
Interim analysis of safety and efficacy of ruxolitinib in patients with myelofibrosis and low platelet counts
|
Talpaz, Moshe
|
|
2013
|
6 |
1 |
|
artikel
|
| 55 |
Journal of Hematology & Oncology reviewer acknowledgement 2012
|
Liu, Delong
|
|
2013
|
6 |
1 |
|
artikel
|
| 56 |
L1cam promotes tumor progression and metastasis and is an independent unfavorable prognostic factor in gastric cancer
|
Chen, Dong-liang
|
|
2013
|
6 |
1 |
|
artikel
|
| 57 |
Leukemic transformation driven by an ASXL1 mutation after a JAK2V617F-positive primary myelofibrosis: clonal evolution and hierarchy revealed by next-generation sequencing
|
Ferrer-Marín, Francisca
|
|
2013
|
6 |
1 |
|
artikel
|
| 58 |
Long non-coding RNA: a new player in cancer
|
Zhang, Hua
|
|
2013
|
6 |
1 |
|
artikel
|
| 59 |
Long-term complete remission with belinostat in a patient with chemotherapy refractory peripheral t-cell lymphoma
|
Reimer, Peter
|
|
2013
|
6 |
1 |
|
artikel
|
| 60 |
Lynch syndrome related endometrial cancer: clinical significance beyond the endometrium
|
Wang, Yiying
|
|
2013
|
6 |
1 |
|
artikel
|
| 61 |
Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy
|
Sahani, Dushyant V
|
|
2013
|
6 |
1 |
|
artikel
|
| 62 |
MEK and the inhibitors: from bench to bedside
|
Akinleye, Akintunde
|
|
2013
|
6 |
1 |
|
artikel
|
| 63 |
miR-363-5p regulates endothelial cell properties and their communication with hematopoietic precursor cells
|
Costa, Ana
|
|
2013
|
6 |
1 |
|
artikel
|
| 64 |
Monitoring of minimal residual disease (MRD) is useful to predict prognosis of adult patients with Ph-negative ALL: results of a prospective study (ALL MRD2002 Study)
|
Nagafuji, Koji
|
|
2013
|
6 |
1 |
|
artikel
|
| 65 |
Notch1 is required for hypoxia-induced proliferation, invasion and chemoresistance of T-cell acute lymphoblastic leukemia cells
|
Zou, Jie
|
|
2013
|
6 |
1 |
|
artikel
|
| 66 |
Novel agents and biomarkers for acute lymphoid leukemia
|
Zhao, Yanmin
|
|
2013
|
6 |
1 |
|
artikel
|
| 67 |
Novel agents for chronic lymphocytic leukemia
|
Wu, Mei
|
|
2013
|
6 |
1 |
|
artikel
|
| 68 |
Optimizing management of ruxolitinib in patients with myelofibrosis: the need for individualized dosing
|
Mesa, Ruben A
|
|
2013
|
6 |
1 |
|
artikel
|
| 69 |
PAX8: a sensitive and specific marker to identify cancer cells of ovarian origin for patients prior to neoadjuvant chemotherapy
|
Wang, Yue
|
|
2013
|
6 |
1 |
|
artikel
|
| 70 |
Perioperative therapy for locally advanced gastroesophageal cancer: current controversies and consensus of care
|
Sehdev, Amikar
|
|
2013
|
6 |
1 |
|
artikel
|
| 71 |
Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
|
Akinleye, Akintunde
|
|
2013
|
6 |
1 |
|
artikel
|
| 72 |
Population level survival of patients with chronic myelocytic leukemia in Germany compared to the US in the early 21st century
|
Pulte, Dianne
|
|
2013
|
6 |
1 |
|
artikel
|
| 73 |
Presence of alternative lengthening of telomeres associated circular extrachromosome telomere repeats in primary leukemia cells of chronic myeloid leukemia
|
Samassekou, Oumar
|
|
2013
|
6 |
1 |
|
artikel
|
| 74 |
Proliferation inhibition and apoptosis induction of imatinib-resistant chronic myeloid leukemia cells via PPP2R5C down-regulation
|
Shen, Qi
|
|
2013
|
6 |
1 |
|
artikel
|
| 75 |
Protein biomarkers distinguish between high- and low-risk pediatric acute lymphoblastic leukemia in a tissue specific manner
|
Braoudaki, Maria
|
|
2013
|
6 |
1 |
|
artikel
|
| 76 |
Rapid induction of complete molecular remission by sequential therapy with LDAC and sorafenib in FLT3-ITD-positive patients unfit for intensive treatment: two cases and review of the literature
|
Wolleschak, Denise
|
|
2013
|
6 |
1 |
|
artikel
|
| 77 |
Role of platelet chemokines, PF-4 and CTAP-III, in cancer biology
|
Pilatova, Katerina
|
|
2013
|
6 |
1 |
|
artikel
|
| 78 |
Selenium and sulindac are synergistic to inhibit intestinal tumorigenesis in Apc/p21 mice
|
Bi, Xiuli
|
|
2013
|
6 |
1 |
|
artikel
|
| 79 |
Signal transduction inhibitors in treatment of myelodysplastic syndromes
|
Bachegowda, Lohith
|
|
2013
|
6 |
1 |
|
artikel
|
| 80 |
Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia
|
Alachkar, Houda
|
|
2013
|
6 |
1 |
|
artikel
|
| 81 |
SNS-032 inhibits mTORC1/mTORC2 activity in acute myeloid leukemia cells and has synergistic activity with perifosine against Akt
|
Meng, Haitao
|
|
2013
|
6 |
1 |
|
artikel
|
| 82 |
Sodium selenite alters microtubule assembly and induces apoptosis in vitro and in vivo
|
Shi, Kejian
|
|
2013
|
6 |
1 |
|
artikel
|
| 83 |
STAT inhibitors for cancer therapy
|
Furqan, Muhammad
|
|
2013
|
6 |
1 |
|
artikel
|
| 84 |
STAT3 mutations are frequent in T-cell large granular lymphocytic leukemia with pure red cell aplasia
|
Qiu, Zhi-Yuan
|
|
2013
|
6 |
1 |
|
artikel
|
| 85 |
Stem cell factor SALL4, a potential prognostic marker for myelodysplastic syndromes
|
Wang, Fei
|
|
2013
|
6 |
1 |
|
artikel
|
| 86 |
Structurally differentiated cis-elements that interact with PU.1 are functionally distinguishable in acute promyelocytic leukemia
|
Qian, Maoxiang
|
|
2013
|
6 |
1 |
|
artikel
|
| 87 |
Targeted therapy for HER2 positive breast cancer
|
Incorvati, Jason A
|
|
2013
|
6 |
1 |
|
artikel
|
| 88 |
Targeting MET kinase with the small-molecule inhibitor amuvatinib induces cytotoxicity in primary myeloma cells and cell lines
|
Phillip, Cornel Joseph
|
|
2013
|
6 |
1 |
|
artikel
|
| 89 |
Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers
|
Li, Xinyuan
|
|
2013
|
6 |
1 |
|
artikel
|
| 90 |
Targeting p53 by small molecules in hematological malignancies
|
Saha, Manujendra N
|
|
2013
|
6 |
1 |
|
artikel
|
| 91 |
TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity
|
Stavik, Benedicte
|
|
2013
|
6 |
1 |
|
artikel
|
| 92 |
The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies
|
Shi, Li
|
|
2013
|
6 |
1 |
|
artikel
|
| 93 |
The serum levels of the cytokines involved in the Th17 and Th1 cell commitment are increased in individuals with borderline thrombocytopenia
|
Rocha, Andreia Maria Camargos
|
|
2013
|
6 |
1 |
|
artikel
|
| 94 |
Validation of the M. D. Anderson Symptom Inventory multiple myeloma module
|
Jones, Desiree
|
|
2013
|
6 |
1 |
|
artikel
|
Tijdschrift beschrijving